FOXP3 and amyotrophic lateral sclerosis: Together, these prospective results suggest that in the ALS pathogenic process Tregs and Th2 lymphocytes slow disease progression rates, and that as the numbers of these cells decline and FoxP3 and Gata3 expressions are reduced, disease progression rates accelerate.